Elimination of heparin interference during microarray processing of fresh and biobank-archived blood samples

Environmental and Molecular Mutagenesis

Volumn 55, Issue 6, 2014, Pages 482-491

  Hebels, Dennie G A J ^a   van Herwijnen, Marcel H M ^a   Brauers, Karen J J ^a   de Kok, Theo M C M ^a   Chalkiadaki, Georgia ^b   Kyrtopoulos, Soterios A ^c   Kleinjans, Jos C S ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF CRETE   (Greece)

^c INSTITUTE OF BIOLOGY   (Greece)

Author keywords

Biobank samples; Blood; Fluorophore PCR labelling; Heparin interference; Lithium chloride treatment; Transcriptomics

Indexed keywords

CITRIC ACID; EDETIC ACID; HEPARIN; MESSENGER RNA; RNA; RNA POLYMERASE; FLUORESCENT DYE; LITHIUM CHLORIDE;

ADULT; ARTICLE; BLOOD BANK; BLOOD SAMPLING; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; RNA SYNTHESIS; ROOM TEMPERATURE; STORAGE; BLOOD; BLOOD ANALYSIS; METABOLISM; PROCEDURES; QUALITY CONTROL; TEMPERATURE;

BLOOD BANKS; BLOOD CHEMICAL ANALYSIS; FLUORESCENT DYES; HEPARIN; HUMANS; LITHIUM CHLORIDE; MICROARRAY ANALYSIS; QUALITY CONTROL; RNA; TEMPERATURE;

EID: 84903815558     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21869     Document Type: Article

References (32)

1. Amersham Biosciences. 2003. Application Note 18-1118-32 AB: Partial Purification of DNA Binding Proteins Using HiTrap Heparin HP. Amersham Biosciences. pp 1-6.
2. Bai X, Fischer S, Keshavjee S, Liu M. 2000. Heparin interference with reverse transcriptase polymerase chain reaction of RNA extracted from lungs after ischemia-reperfusion. Transpl Int 13:146-150.
3. Beecher CN, Young RP, Langeslay DJ, Mueller LJ, Larive CK. 2014. Hydroxyl-proton hydrogen bonding in the heparin oligosaccharide Arixtra in aqueous solution. J Phys Chem B 118:482-491.
4. Berg JM, Tymoczko JL, Stryer L. 2002. Biochemistry, 5th ed. New York, NY: W. H. Freeman. 1050 p.
5. Beutler E, Gelbart T, Kuhl W. 1990. Interference of heparin with the polymerase chain reaction. Biotechniques 9:166.
6. Bolstad BM, Irizarry RA, Astrand M, Speed TP. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193.
7. Chadderton T, Wilson C, Bewick M, Gluck S. 1997. Evaluation of three rapid RNA extraction reagents: Relevance for use in RT-PCR's and measurement of low level gene expression in clinical samples. Cell Mol Biol 43:1227-1234.
8. Chatzi L, Plana E, Daraki V, Karakosta P, Alegkakis D, Tsatsanis C, Kafatos A, Koutis A, Kogevinas M. 2009. Metabolic syndrome in early pregnancy and risk of preterm birth. Am J Epidemiol 170:829-836.
9. Cicinnati VR, Shen Q, Sotiropoulos GC, Radtke A, Gerken G, Beckebaum S. 2008. Validation of putative reference genes for gene expression studies in human hepatocellular carcinoma using real-time quantitative RT-PCR. BMC Cancer 8:350.
10. Coad JE, Lander TA, Litz CE. 1992. Inhibition of restriction endonucleases by common clinical anticoagulants. Anal Biochem 205:368-369.
11. Covino J, Strezoska Z, Kelley M. 2013. Tech Note: Thermo Scientific Solaris RNA Spike Control Kit: Identifying Reaction Inhibition in the RT-qPCR Workflow. Thermo Scientific. pp 1-11.
12. del Prete MJ, Vernal R, Dolznig H, Mullner EW, Garcia-Sanz JA. 2007. Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments. RNA 13:414-421.
13. Ellinger-Ziegelbauer H, Aubrecht J, Kleinjans JC, Ahr HJ. 2009. Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity. Toxicol Lett 186:36-44.
14. Gerard GF. 1994. Inhibition of SuperScript™ II reverse transcriptase by common laboratory chemicals. Focus 16:102-103.
15. Gościańska J, Olejnik A, Sobieszczuk E, Latanowicz K, Nowak I. 2011. Significance of UV-Vis spectroscopy in in vitro release studies. CHEMIK 65:649-654.
16. Goulian M, Heard CJ. 1990. An inhibitor of DNA polymerases alpha and delta in calf thymus DNA. Nucleic Acids Res 18:4791-4796.
17. Hebels DG, Georgiadis P, Keun HC, Athersuch TJ, Vineis P, Vermeulen R, Portengen L, Bergdahl IA, Hallmans G, Palli D, Bendinelli B, Krogh V, Tumino R, Sacerdote C, Panico S, Kleinjans JC, de Kok TM, Smith MT, Kyrtopoulos SA. 2013. Performance in omics analyses of blood samples in long-term storage: Opportunities for the exploitation of existing biobanks in environmental health research. Environ Health Perspect 121:480-487.
18. Holodniy M, Kim S, Katzenstein D, Konrad M, Groves E, Merigan TC. 1991. Inhibition of human immunodeficiency virus gene amplification by heparin. J Clin Microbiol 29:676-679.
19. Johnson ML, Navanukraw C, Grazul-Bilska AT, Reynolds LP, Redmer DA. 2003. Heparinase treatment of RNA before quantitative real-time RT-PCR. Biotechniques 35:1140-1142, 1144.
20. Jung R, Lubcke C, Wagener C, Neumaier M. 1997. Reversal of RT-PCR inhibition observed in heparinized clinical specimens. Biotechniques 23:24, 26, 28.
21. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. 2004. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103:1669-1675.
22. McHale CM, Zhang L, Hubbard AE, Smith MT. 2010. Toxicogenomic profiling of chemically exposed humans in risk assessment. Mutat Res 705:172-183.
23. Poli F, Cattaneo R, Crespiatico L, Nocco A, Sirchia G. 1993. A rapid and simple method for reversing the inhibitory effect of heparin on PCR for HLA class II typing. PCR Methods Appl 2:356-358.
24. Satsangi J, Jewell DP, Welsh K, Bunce M, Bell JI. 1994. Effect of heparin on polymerase chain reaction. Lancet 343:1509-1510.
25. Taylor AC. 1997. Titration of heparinase for removal of the PCR-inhibitory effect of heparin in DNA samples. Mol Ecol 6:383-385.
26. Todd DM, Buccini FJ. 1993. Apparent heparin interference with restriction enzyme digestion of genomic DNA. Clin Chem 39:362-363.
27. von Alhfen S, Schlumpberger M. 2010. Effects of low A260/A230 ratios in RNA preparations on downstream applications. Qiagen. pp 7-8.
28. Wallace DM. 1987. Precipitation of nucleic acids. Methods Enzymol 152:41-48.
29. Walter G, Zillig W, Palm P, Fuchs E. 1967. Initiation of DNA-dependent RNA synthesis and the effect of heparin on RNA polymerase. Eur J Biochem/FEBS 3:194-201.
30. Wang P, Jiang L, Li Y, Chen Z, Meng M, Zou H, Hou Z. 2007. Optimization of test conditions: Heparinase and lithium chloride can reduce the inhibition effect of heparin on β-actin amplifications during RT-PCR. J Clin Exp Med 6:27-29.
31. Yokota M, Tatsumi N, Nathalang O, Yamada T, Tsuda I. 1999. Effects of heparin on polymerase chain reaction for blood white cells. J Clin Lab Anal 13:133-140.
32. Zhu Z, Chao J, Yu H, Waggoner AS. 1994. Directly labeled DNA probes using fluorescent nucleotides with different length linkers. Nucleic Acids Res 22:3418-3422.